Lv4
790 积分 2023-09-05 加入
The clinical landscape of CAR NK cells
9小时前
待确认
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
9小时前
已完结
Resetting autoimmune disease with CAR cell therapies
9小时前
已完结
The race to reset autoimmune diseases
4天前
已完结
Sequential immunotherapy: towards cures for autoimmunity
4天前
已完结
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
4天前
已完结
Research progress of CXCR3 inhibitors
4天前
已完结
The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology
4天前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
5天前
已完结
皖公网安备34019202002308
